Skip to main content
Q

QuantaMatrix Incorporated — Investor Relations & Filings

Ticker · 317690 ISIN · KR7317690006 KO Manufacturing
Open in API
Filings indexed 155 across all filing types
Latest filing 2025-12-30 Capital/Financing Update
Country KR South Korea
Listing KO 317690

About QuantaMatrix Incorporated

https://www.quantamatrix.com/

QuantaMatrix Incorporated is an in-vitro diagnostics (IVD) company specializing in the development and manufacturing of medical devices using microbial diagnostics technology. The company focuses on providing rapid diagnostic solutions for critical conditions, with a primary emphasis on sepsis. Its flagship product, dRAST™ (direct & Rapid Antimicrobial Susceptibility Test), significantly reduces the time for determining effective antibiotics for sepsis patients, providing results in as few as four hours from a positive blood culture, compared to several days for conventional methods. This technology, which utilizes microfluidic channels and time-lapse microscopic imaging, enables faster, targeted antimicrobial therapy. In addition to sepsis, QuantaMatrix develops diagnostic solutions for other areas, including tuberculosis (QDST™), Alzheimer's disease (QPLEX™), and cardiovascular diseases.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Capital/Financing Update Classification · 1% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from QuantaMatrix. It details the final issuance of convertible bonds (36 billion KRW), including the payment date and issuance method. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2025-12-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, voting rights, and major contracts (such as voting rights delegation and share transfer restrictions) by a major shareholder (Ezrah Charitable Trust) in the company QuantaMatrix. This falls under the category of Major Shareholding Notification.
2025-12-30 Korean
전환청구권행사
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from QuantaMatrix regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued upon conversion, the remaining balance of convertible bonds, and the conversion price. This type of disclosure regarding capital structure changes and share issuance resulting from debt conversion falls under the 'Share Issue/Capital Change' category.
2025-12-30 Korean
[기재정정]경영권변경등에관한계약체결
Board/Management Information Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Change in Management Control' (경영권 변경 등에 관한 계약 체결). It details the contract between the current management/major shareholders and a new investment fund (PentaStone 3rd New Technology Investment Fund) involving the issuance of convertible bonds to transfer control. This falls under M&A activity and corporate control changes, which is classified as TAR (M&A Activity) in the provided schema.
2025-12-26 Korean
경영권변경등에관한계약체결
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing regarding a 'Change in Management Control' (경영권 변경 등에 관한 계약 체결) involving the issuance of convertible bonds to a new investor. This type of corporate event, which involves significant changes in ownership structure and management control, is classified under M&A Activity (TAR) as it pertains to the transfer of control and strategic investment agreements.
2025-12-24 Korean
주요사항보고서(자본으로인정되는채무증권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission in South Korea. It details the decision to issue convertible bonds (debt securities recognized as capital), including specific terms such as interest rates, conversion prices, and the use of proceeds. This falls under the category of capital structure changes and financing activities, which is classified as 'CAP' (Capital/Financing Update).
2025-12-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.